OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31

OPKO HEALTH, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Aug 28, 2026

$1.61+0.08 (+5.23%)

Close on Oct 19, 2026

Market cap: $1.22B
P/E (TTM): –
Dividend yield: –

Dividends

Opko Health has not reported a dividend

No dividend per share appears in Opko Health's annual filings since fiscal 2010.

Where these numbers come from

Parsed from the XBRL in Opko Health's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is OPK.

Revenue growth-11.5% · median 17.5%

Operating margin-8.2% · median -71.4%

Net margin-12.4% · median -51.7%

Company	Revenue	Growth
RARE	$717.21M	+17.5%
OPK	$587.90M	-11.5%
MNKD	$393.63M	+30.5%
HCM	$204.89M	-4.3%
TLX	–	–
EVO	–	–

Company

Next earnings (est.): Oct 28, 2026, after close
Exchange: Nasdaq
Industry: Pharmaceutical Preparations
Fiscal year ends: December 31
Employees: 2,275
Held by institutions: 27.2%
Auditor: Ernst & Young LLP
SEC CIK: 944809

Advertisement
300 × 250